Retrospective Study of Incidence & Etiology of Reoperation After Primary

See also
Status	Clinical Trial	Phase
Completed	`NCT02551939` - Breast Fat Grafting Augmentation in Chinese Women	N/A
Completed	`NCT01244698` - Postoperative Antibiotic Requirements Following Immediate Breast Reconstruction	Phase 4
Completed	`NCT02438332` - Retrospective Study of Reoperation After Primary Augmentation With NATRELLE® INSPIRA® Breast Implants	N/A
Not yet recruiting	`NCT03477565` - Kinesio Tex Tape in Reducing Edema and Seroma After Complex Reconstructive Breast Surgery	N/A

See also

Status

Clinical Trial

Phase

Completed

NCT02551939 - Breast Fat Grafting Augmentation in Chinese Women

N/A

Completed

NCT01244698 - Postoperative Antibiotic Requirements Following Immediate Breast Reconstruction

Phase 4

Completed

NCT02438332 - Retrospective Study of Reoperation After Primary Augmentation With NATRELLE® INSPIRA® Breast Implants

N/A

Not yet recruiting

NCT03477565 - Kinesio Tex Tape in Reducing Edema and Seroma After Complex Reconstructive Breast Surgery

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT02132572
Study type	Observational
Source	Allergan
Contact
Status	Completed
Phase	N/A
Start date	March 2014
Completion date	April 2015

Retrospective Study of Incidence and Etiology of Reoperation After Primary Augmentation With Natrelle® Breast Implants — RANBI

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms